DrugPatentWatch Database Preview
ANTHELIOS 20 Drug Profile
When do Anthelios 20 patents expire, and when can generic versions of Anthelios 20 launch?
The generic ingredient in ANTHELIOS 20 is avobenzone; ecamsule; octocrylene; titanium dioxide. There are two drug master file entries for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene; titanium dioxide profile page.
Summary for ANTHELIOS 20
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | see details |
DailyMed Link: | ANTHELIOS 20 at DailyMed |

US Patents and Regulatory Information for ANTHELIOS 20
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Loreal Usa | ANTHELIOS 20 | avobenzone; ecamsule; octocrylene; titanium dioxide | CREAM;TOPICAL | 021471-001 | Oct 5, 2006 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |